The Company is pleased to announce its results concerning the safety and efficacy of the Company’s Deep TMS device for treating medication-resistant major depressive disorder (in patients who failed to respond, or responded only partially, to at least two antidepressant medications), which were reported to the Helsinki Committee of the Shalvata Mental Health Center on 8 August 2007.
Brainsway received the Medical Futures Innovation Award 2007 for the most promising new treatment
20 June, 2007
Brainsway received the Medical Futures Innovation Award of 2007 in the category of mental health & neuroscience, for the most promising new treatment. Brainsway has won the award for its unique Deep TMS technology, aimed for the non-invasive treatment of various neurological and psychiatric disorders. The ceremony was held on the 14/06/07 in London.
Brainsway won the Medical Futures Innovation Awards 2007
27 April, 2007
Brainsway has won the Medical Futures Innovation Awards of 2007 in the category of Mental Health & Neuroscience. The Medical Futures Innovation Award is the United Kingdom's most sought after healthcare award, supported by the UK prime minister. The award is aimed to encourage, support and reward clinical and commercial excellence from the healthcare & life sciences professions.
The criteria for the award emphasize the potential benefit for patients, the novelty and the technical and commercial applicability.
Brainsway has won the award for its unique Deep TMS technology, aimed for the non-invasive treatment of various neurological and psychiatric disorders.
A new clinical trial in treatment of depression at Hadassah
12 April, 2007
A new clinical study has begun in Hadassah Ein-Kerem Medical Center, Israel, using Deep TMS in augmentation to antidepressant medication, for the treatment of major depression.
Home
Site Map
Contact Us
Send to a friend
Print page
